• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

TetraScience & Microsoft Partner to Advance Scientific AI in Biopharma

by Fred Pennic 01/16/2025 Leave a Comment

TetraScience & Microsoft Partner to Advance Scientific AI in Biopharma

What You Should Know:  - TetraScience, a provider of scientific data cloud solutions announced a strategic collaboration with Microsoft to accelerate the adoption of artificial intelligence (AI) in the biopharmaceutical industry.  - The strategic partnership combines TetraScience's Scientific Data and AI Cloud with the power and security of Microsoft Azure, creating a robust platform for scientific organizations to extract valuable insights from their complex experimental
Read More

Is AI Failing Drug Development? The Unseen Challenges

by Noam Solomon, CEO at Immunai 01/16/2025 Leave a Comment

Is AI Failing Drug Development? The Unseen Challenges

For over a decade, we've heard about AI's transformative potential in therapeutics (Tx), but where's the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there something the AI experts aren't telling us? First, some facts. The process of Tx development—from early clinical trials to FDA approval—is excruciatingly slow (over 10 years), expensive (over $2B, especially for immunotherapy drugs), and comes with a low probability of success (5% in Immune-Oncology, and similarly
Read More

Increasing Participation in Muscular Dystrophy Clinical Trials

by Michel van Harten M.D., CEO of myTomorrows 01/15/2025 Leave a Comment

Increasing Participation in Muscular Dystrophy Clinical Trials

Muscular Dystrophy (MD) refers to a group of rare genetic conditions that cause progressive muscle weakness and degeneration in patients. Some forms of MD, such as Duchenne Muscular Dystrophy (DMD), can be life threatening to heart and respiratory functions.  But recent research found that among 3,661 U.S. patients with Muscular Dystrophy, only 33% of those with Duchenne and 12% of those with Becker Muscular Dystrophy - a similar but milder and later-onset MD condition - have previously
Read More

Lantheus (LNTH) Acquires Life Molecular Imaging for $750M

by Fred Pennic 01/14/2025 Leave a Comment

Lantheus (LNTH) Acquires Life Molecular Imaging for $750M

What You Should Know:  - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leading radiopharmaceutical company, announced a definitive agreement to acquire Life Molecular Imaging Ltd. for $350M upfront and up to an additional $400M in potential earn-out and milestone payments.  - The strategic acquisition strengthens Lantheus' position in the radiopharmaceutical market and establishes a commercial presence in the Alzheimer's disease (AD) space. Life Molecular Imaging
Read More

Broad Institute & Manifold Partner to Develop AI Research Platform

by Jasmine Pennic 01/13/2025 Leave a Comment

Broad Institute & Manifold Partner to Develop AI Research Platform

What You Should Know:  - The Broad Institute of MIT and Harvard is collaborating with Manifold, a leader in AI-powered research infrastructure, to develop a next-generation platform for biomedical research.  - The strategic partnership aims to enhance data analysis, secure sharing, and global collaboration, empowering scientists worldwide to accelerate discovery. Manifold: Accelerating Biomedical Research with AI Founded in 2016, Manifold's AI-powered platform streamlines
Read More

Rubicon Founders Invests $165M in Caidya to Fuel Global Expansion

by Fred Pennic 01/13/2025 Leave a Comment

Rubicon Founders Invests $165M in Caidya to Fuel Global Expansion

What You Should Know:  - Caidya, a global mid-sized clinical research organization (CRO), announced today a $165 million strategic growth investment from funds managed by Rubicon Founders, a healthcare investment firm focused on building and growing transformative companies.  - The strategic investment will support Caidya's continued expansion and its mission to accelerate the development of innovative therapies for unmet medical needs. Fueling Growth and Strategic
Read More

Open Source in Life Sciences: Balancing Innovation and Compliance

by Christopher McSpiritt, Head of life sciences at Domino Data Lab 01/10/2025 Leave a Comment

Open Source in Life Sciences: Balancing Innovation and Compliance

Data science teams in the life sciences industry are experiencing a significant change that will transform how clinical data is analyzed, opening the door to new possibilities for innovation. The transition isn’t happening overnight, but such incremental approaches are necessary to ensure success in such a highly regulated environment. For decades, SAS was “it” in life sciences. If you wanted to be a data scientist in the industry, you had to know SAS. However, recently there has been a move
Read More

Medidata Platform Enhances Clinical Trial Efficiency for Bristol Myers Squibb

by Syed Hamza Sohail 01/08/2025 Leave a Comment

Medidata Platform Enhances Clinical Trial Efficiency for Bristol Myers Squibb

What You Should Know: - Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has announced an extended and expanded partnership with Bristol Myers Squibb (BMS). -  This collaboration aims to enhance clinical research processes, improve patient outcomes, and foster advancements in personalized healthcare.  Medidata and Bristol Myers Squibb Strengthen Partnership to Advance Clinical Research and Personalized Healthcare  As
Read More

Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery

by Fred Pennic 01/07/2025 Leave a Comment

Pepticom Secures $6.6M to Advance AI-Powered Peptide Drug Discovery

What You Should Know:  - Pepticom, an innovator in AI-driven peptide-based therapeutics secures $6.6M in a Series A1 funding round led by Japan Israel High Tech Ventures 2 LP, with strong support from existing investors.  - The new funding will accelerate the development of Pepticom's oral IL-17 inhibitor program, focusing on creating improved treatments for autoimmune diseases like psoriasis and psoriatic arthritis. Revolutionizing Autoimmune Disease Treatment Pepticom is
Read More

ActiGraph Acquires Biofourmis Life Science Business

by Fred Pennic 01/07/2025 Leave a Comment

ActiGraph Acquires Biofourmis Life Science Business

What You Should Know:  - ActiGraph, a global leader in wearable digital health technology, announced the acquisition of Biofourmis Connect, a division of Biofourmis specializing in AI-powered digital trial platforms for the life science industry. Financial terms of the acquisition were not disclosed. - The acquisition combines ActiGraph's expertise in wearable technology with Biofourmis Connect's advanced analytics capabilities, creating a comprehensive and unified solution for
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Go to page 11
  • Go to page 12
  • Interim pages omitted …
  • Go to page 88
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |